loading
Precedente Chiudi:
$2.13
Aprire:
$2.13
Volume 24 ore:
175.65K
Relative Volume:
0.33
Capitalizzazione di mercato:
$191.72M
Reddito:
$7.05M
Utile/perdita netta:
$-30.43M
Rapporto P/E:
-5.755
EPS:
-0.3788
Flusso di cassa netto:
$21.84M
1 W Prestazione:
+0.93%
1M Prestazione:
+22.47%
6M Prestazione:
-21.01%
1 anno Prestazione:
+32.93%
Intervallo 1D:
Value
$2.1067
$2.18
Intervallo di 1 settimana:
Value
$2.00
$2.5398
Portata 52W:
Value
$1.07
$4.62

Proqr Therapeutics N V Stock (PRQR) Company Profile

Name
Nome
Proqr Therapeutics N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
166
Name
Cinguettio
@proqr
Name
Prossima data di guadagno
2025-03-14
Name
Ultimi documenti SEC
Name
PRQR's Discussions on Twitter

Confronta PRQR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PRQR
Proqr Therapeutics N V
2.18 191.72M 7.05M -30.43M 21.84M -0.3788
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Ripresa Cantor Fitzgerald Overweight
2025-04-29 Iniziato Evercore ISI Outperform
2025-03-10 Aggiornamento Citigroup Neutral → Buy
2025-01-10 Iniziato Oppenheimer Outperform
2024-10-29 Aggiornamento Raymond James Outperform → Strong Buy
2023-11-08 Aggiornamento Chardan Capital Markets Neutral → Buy
2023-03-30 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2022-12-22 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2022-02-14 Downgrade Citigroup Buy → Neutral
2022-02-11 Downgrade Raymond James Strong Buy → Mkt Perform
2022-02-11 Downgrade Stifel Buy → Hold
2022-02-01 Iniziato Raymond James Strong Buy
2021-05-03 Iniziato Stifel Buy
2021-03-25 Reiterato Citigroup Buy
2020-11-03 Ripresa Cantor Fitzgerald Overweight
2019-03-12 Reiterato Chardan Capital Markets Buy
2018-12-19 Iniziato RBC Capital Mkts Outperform
2018-11-15 Iniziato Citigroup Buy
2018-09-19 Iniziato Evercore ISI Outperform
2017-09-26 Reiterato JMP Securities Mkt Outperform
2016-06-20 Iniziato Chardan Capital Markets Neutral
2014-10-15 Iniziato Deutsche Bank Buy
2014-10-13 Iniziato H.C. Wainwright Buy
Mostra tutto

Proqr Therapeutics N V Borsa (PRQR) Ultime notizie

pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected - simplywall.st

Jun 13, 2025
pulisher
Jun 13, 2025

Equities Analysts Offer Predictions for PRQR FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

Research Analysts Set Expectations for PRQR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys Shares of 11,400 ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Analysts Set ProQR Therapeutics (NASDAQ:PRQR) Target Price at $8.00 - MarketBeat

Jun 09, 2025
pulisher
Jun 09, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Investments LP Has $1.02 Million Stake in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Grows Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Buys 320,614 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProQR Therapeutics (NASDAQ:PRQR) Sees Significant Increase in Short Interest - MarketBeat

Jun 05, 2025
pulisher
Jun 03, 2025

ProQR Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Purchased by Northern Trust Corp - MarketBeat

Jun 02, 2025
pulisher
May 31, 2025

Millennium Management LLC Grows Stock Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

BNP Paribas Financial Markets Buys 15,900 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 30, 2025
pulisher
May 29, 2025

Northern Trust Corp Has $1.11 Million Stock Holdings in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 29, 2025
pulisher
May 28, 2025

Woodline Partners LP Invests $9.43 Million in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Here's Why ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO May Deserve A Raise - simplywall.st

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Buys 2,683,351 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 27, 2025
pulisher
May 25, 2025

Point72 Asset Management L.P. Buys New Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 25, 2025
pulisher
May 23, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com Canada

May 23, 2025
pulisher
May 19, 2025

Cantor Fitzgerald Issues Negative Forecast for PRQR Earnings - MarketBeat

May 19, 2025
pulisher
May 18, 2025

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 18, 2025
pulisher
May 16, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of "Buy" by Analysts - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Oppenheimer Has Lowered Expectations for ProQR Therapeutics (NASDAQ:PRQR) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

Research Analysts Issue Forecasts for PRQR FY2025 Earnings - Defense World

May 15, 2025
pulisher
May 14, 2025

ProQR (PRQR) Price Target Cut by Oppenheimer Amid Clinical Updates | PRQR Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

DAFNA Capital Management LLC Buys 661,979 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 13, 2025
pulisher
May 13, 2025

ProQR Therapeutics (PRQR) Price Target Lowered by Oppenheimer | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Adjusts ProQR Therapeutics N.V Price Target to $9 From $15, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Raymond James Financial Inc. Invests $260,000 in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 12, 2025
pulisher
May 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 11, 2025
pulisher
May 09, 2025

ProQR: Q1 Earnings Snapshot - News-Times

May 09, 2025
pulisher
May 09, 2025

1,181,413 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by ArrowMark Colorado Holdings LLC - MarketBeat

May 09, 2025
pulisher
May 09, 2025

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR) - simplywall.st

May 09, 2025
pulisher
May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates - Investing.com Australia

May 08, 2025
pulisher
May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

Proqr Therapeutics N V Azioni (PRQR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):